CD4+ and CD8+ T‐lymphocyte scores cannot reliably predict progression in patients with benign prostatic hyperplasia

To determine whether the density of CD4+ and CD8+ T‐lymphocytes in a transrectal ultrasonography (TRUS) biopsy of the prostate can be used to predict the progression of lower urinary tract symptoms (LUTS) in benign prostatic hyperplasia (BPH).

[1]  S. Terry,et al.  Inflammation in benign prostatic hyperplasia: A 282 patients' immunohistochemical analysis , 2009, The Prostate.

[2]  I. Ozdemir,et al.  Combination therapy with doxazosin and tenoxicam for the management of lower urinary tract symptoms. , 2009, Urology.

[3]  D. McMillan,et al.  The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer , 2008, British Journal of Cancer.

[4]  J. Nickel.  Inflammation and benign prostatic hyperplasia. , 2008, The Urologic clinics of North America.

[5]  Long Wang,et al.  Chronic inflammation in benign prostatic hyperplasia: implications for therapy. , 2008, Medical hypotheses.

[6]  G. Kramer,et al.  Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? , 2007, European urology.

[7]  G. Kramer,et al.  Could inflammation be a key component in the progression of benign prostatic hyperplasia? , 2006, Current opinion in urology.

[8]  C. Roehrborn.  10 The impact of acute or chronic inflammation in baseline biopsy on the risk of progression in the MTOPS study , 2005 .

[9]  M. Resnick,et al.  The healthy rat prostate contains high levels of natural killer-like cells and unique subsets of CD4+ helper-inducer T cells: implications for prostatitis. , 2005, The Journal of urology.

[10]  T. Moon,et al.  Diagnosis of prostatic inflammation: efficacy of needle biopsies versus tissue blocks. , 2005, Urology.

[11]  E. Giovannucci,et al.  Serum C‐reactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III) , 2005, The Prostate.

[12]  D. Tindall,et al.  Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial. , 2004, The Journal of urology.

[13]  Patricia D. Castro,et al.  Interleukin‐8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia , 2004, The Prostate.

[14]  D. McMillan,et al.  The relationship between T-lymphocyte subset infiltration and survival in patients with prostate cancer , 2004, British Journal of Cancer.

[15]  M. Ricote,et al.  Immunohistochemical analysis of the IL‐6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate , 2004, The Journal of pathology.

[16]  C. Roehrborn,et al.  The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. , 2003, The New England journal of medicine.

[17]  D. McMillan,et al.  The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer , 2003, British Journal of Cancer.

[18]  G. Kramer,et al.  Cytokine Expression Pattern in Benign Prostatic Hyperplasia Infiltrating T Cells and Impact of Lymphocytic Infiltration on Cytokine mRNA Profile in Prostatic Tissue , 2003, Laboratory Investigation.

[19]  G. Kramer,et al.  Increased expression of lymphocyte‐derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation , 2002, The Prostate.

[20]  L. Appel,et al.  How many patients are necessary to assess test performance? , 1990, JAMA.

[21]  P. Kohnen,et al.  Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study. , 1979, The Journal of urology.

[22]  John A E Anderson,et al.  Observations on the Estimation of the Quantity of Emphysema in the Lungs by the Point-sampling Method , 1965 .